Inclusive of all taxes
Artesunate Injection 60mg by Ancalima Lifesciences Limited is a powerful and rapid-acting antimalarial injectable solution specifically formulated for the treatment of severe malaria, including life-threatening cerebral malaria. This high-efficacy medicament is endorsed by international health authorities as the recommended first-line therapy for quick parasite clearance and reduction of mortality rates in severe malaria cases. The 60mg dosage ensures optimized potency to combat Plasmodium falciparum infections effectively, making it indispensable for hospitals, clinics, and healthcare providers handling critical malaria conditions. Backed by rigorous scientific validation, this injectable Artesunate offers swift action with enhanced patient recovery rates, delivering reliable and life-saving intervention in endemic regions and emergency treatment scenarios.
Key Features
| Features | Description |
|---|---|
| Dosage Strength | 60mg per injection |
| Therapeutic Use | Treatment of severe and cerebral malaria |
| Action Speed | Rapid acting with fast parasite clearance |
| Global Endorsement | Recommended first-line therapy by WHO and global health authorities |
| Formulation Type | Injectable solution for quick systemic effect |
| Efficacy | Significantly reduces malaria mortality rates |
| Target Pathogen | Plasmodium falciparum |
| Clinical Validation | Scientifically proven for severe malaria treatment |
| Packaging | Bulk supply suitable for hospitals and clinics |
| Minimum Order Quantity (MOQ) | 10000 units |
| Attributes | Description |
|---|---|
| Active Ingredient | Artesunate 60mg |
| Form | Injection solution |
| Indication | Severe malaria including cerebral malaria |
| Administration Route | Intravenous or intramuscular injection |
| Packaging Type | Bulk pack for B2B supply |
| Shelf Life | As per manufacturer standards |
| Storage Conditions | Store below 30°C, protect from light |
| Compliance | Meets international pharmaceutical standards |
| Manufacturer | Ancalima Lifesciences Limited |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, Artesunate Injection 60mg is specifically recommended for treating severe and cerebral malaria caused by Plasmodium falciparum.
The injection is administered intravenously or intramuscularly for rapid systemic effect.
Yes, it is endorsed by global health authorities including WHO and compliant with international pharmaceutical quality standards.
The MOQ for bulk ordering Artesunate Injection 60mg from Ancalima Lifesciences Limited is 10,000 units.
It should be stored below 30°C and protected from light to maintain its efficacy.
Country Of Origin: India
Artesunate Injection 60mg is a rapid-acting antimalarial solution for severe malaria cases, endorsed by global health bodies for swift parasite elimination and mortality reduction.
Artesunate Injection 60 mg is a potent formula designed to combat severe malaria infections, including cerebral malaria provoked by Plasmodium falciparum. With its fast-acting nature, it serves as a critical first-line therapy recommended for its efficacy in parasite control and mortality decrease.
Recommended by international health authorities, Artesunate Injection 60mg is hailed for its rapid parasite clearance capability and life-saving impact in critical malaria cases. This formulation stands as a beacon in the fight against malaria-related fatalities and provides hope for those affected by the disease.
Artesunate Injection 60 mg has undergone rigorous scientific scrutiny, emerging as a reliable solution for severe malaria treatment. Its proven ability to swiftly clear parasites and improve patient outcomes underscores its significance in the medical community's efforts to combat malaria infections effectively.
Inclusive of all taxes
You Save: 0
